July 18, 2017
Scalable. Flexible. Secure. The shifting regulatory environment demands a technology platform that responds to current demands and anticipates future requirements.
The specialized services and diverse operations at WDSrx rely on a robust technology infrastructure to maintain current operations and to anticipate future demands. Information Technology professionals benefit from the WDSrx technology team that stresses data security, real-time access, regulatory compliance and automated reporting.
Industry-leading technology enables the WDSrx team to increase operational efficiency while providing the highest level of personalized support. Regular upgrades to our systems maximize ease of use, add new features and improve data integrity and security.
The sophisticated Information Technology backbone creates client benefits including increased information transparency about inventory levels, automation of financial services and minimizing frustration from integration of existing client software and hardware systems with WDSrx technology.
Significant investments in our Information Technology backbone are readying WDSrx in advance of future Drug Supply Chain Security Act (DSCSA) regulations for Serialization and Track and Trace pertaining to Third Party Logistics Providers.
Clients may choose to take advantage of several integrated technology programs designed to increase efficiency while reducing expenses:
WDSrx invests in software and hardware to comply with the Federal Drug Supply Chain Security Act (DSCSA) requiring a system to identify and trace certain prescription drugs as they are distributed in the United States. WDSrx is in compliance with the evolving track and trace mandates including DSCSA-required barcode specifications using the UCC 128 GS1 standard for prescription drugs containing best before dates, batch numbers, quantities, weights and other attributes.
A proprietary online portal specific to each client displaying real-time information about inventory status and financial details with customized reporting options
WDSrx technology manages the entire business process for receiving and processing sales including order placement, order fulfillment, order invoicing, payment, collection and customer care.
WDSrx Information Technology team can assist with customized integration of Enterprise Resource Planning software for tighter control and information transparency
Electronic Data Interchange provides standards for transferring data electronically. The WDSrx team works with each client to establish the parameters for the transfer of data between WDSrx and client automated systems. Examples of EDI document transfers may include purchase orders (EDI 850), Order-to-Invoice (EDI 810) and ASN- Advance Shipping Notices (EDI 856).
The Federal Drug Enforcement Agency’s CSOS (Controlled Substance Ordering System) program allows for secure electronic Controlled Substance orders. WDSrx utilizes this technology on behalf of clients to minimize paperwork, reduce transaction time, increase order accuracy and decrease cost.
The Office of Diversion Control in the Federal Drug Enforcement Agency operates the Automation of Reports and Consolidated Orders System known as ARCOS. ARCOS is a drug reporting system which monitors the flow of DEA Controlled Substances. The Federal Controlled Substances Act of 1970 requires all Controlled Substances transactions to be recorded by the Office of the U.S. Attorney General.
Please allow us to contact you to discuss your 3PL pharmaceutical technology requirements.
Warehousing and Distribution – Confidence Beyond Compliance. Promoting the safe and efficient delivery of pharmaceutical drug products to benefit patient health.
Financial Services – Technology. Security. Convenience. Reduce back-office functions with diversified financial services management to improve cash flow and streamline operations.
Facilities and Equipment – Multiple DCs. 50 States. Modern equipment and advantageous locations speed delivery around the country.
Regulatory Compliance and Industry Participation – Effective Risk Management. Industry-leading procedures to mitigate supply chain risk and maintain regulatory compliance.
Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at email@example.com or (561) 998-3885 x316.